Pure Biologics is a biopharmaceutical company that focuses on the discovery and development of biological drugs and non-systemic therapies. With headquarters and laboratories located in Wrocław, Poland, Pure Biologics has been operating since 2010 and has grown to become one of the largest biotechnology companies in the country. The company specializes in areas such as immuno-oncology, autoimmunology, and rare neurological diseases.

Pure Biologics offers a range of products and services, including the selection and characterization of antibodies and aptamers, protein production, purification, and analysis. They also provide commercial partnership options for early-phase biological drug discovery and development. With a highly experienced research staff, cutting-edge infrastructure, and extensive expertise in aptamer and antibody selection, Pure Biologics collaborates with pharmaceutical and biotechnological companies globally.

In addition to their current portfolio of immunooncology therapies and non-systemic treatments for autoimmune, neurodegenerative, and rare diseases, Pure Biologics is actively engaged in contract research, providing expertise in aptamers, antibodies, and proteins. Their solutions combine the talent of highly qualified scientists, advanced technology platforms, and years of operational experience. With a focus on stable and balanced development, Pure Biologics aims to achieve financial independence and profits by commercializing therapeutic candidates.

Their ultimate goal is to continue innovating and developing advanced therapies to address the needs of patients around the world